Bioepuivalence Study for the Safety and the Pharmacokinetics of DWJ1589 and DWC202315

Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1622, DWC202313, and DWC202314 in Healthy Volunteers Under Fasting Conditions

NCT07260851 ·Status: RECRUITING ·Phase: PHASE1

Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 With DWC202307 in Healthy Adult Volunteers

NCT05954338 ·Status: UNKNOWN ·Phase: PHASE1

Safety and Pharmacokinetics Study of DWC20155 and DWC20156 in Healthy Subjects

NCT02952547 ·Status: COMPLETED ·Phase: PHASE1

Safety and Pharmacokinetics Study of Fixed Dose Combination of DWJ1386 Compared With Co-administration of DWC20155 and DWC20156 in Healthy Subjects

NCT03016494 ·Status: UNKNOWN ·Phase: PHASE1

Pharmacokinetics and Safety Study of DWJ1392 and DWC20164 in Healthy Male Volunteers

NCT03016520 ·Status: UNKNOWN ·Phase: PHASE1

Pharmacokinetics and Safety, Tolerability of DWJ211in Healthy Volunteers

NCT04159961 ·Status: COMPLETED ·Phase: PHASE1

PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers

NCT07144176 ·Status: RECRUITING ·Phase: PHASE1

Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition.

NCT07267221 ·Status: RECRUITING ·Phase: PHASE1

PK and Safety Comparison of DWJ445 and DWC202506 in Healthy Volunteers

NCT07256600 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics and Safety Following Administration of DWP16001

NCT05414591 ·Status: COMPLETED ·Phase: PHASE1

Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fasting State

NCT05739851 ·Status: UNKNOWN ·Phase: PHASE1

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809-T2

NCT05214690 ·Status: COMPLETED ·Phase: PHASE1

This Study is to Compare and Evaluate the Safety and Pharmacokinetic Characteristics (PK) After Administration of DW6014 and Each Component in Healthy Adult Volunteers in Fed Condition.

NCT05823883 ·Status: UNKNOWN ·Phase: PHASE1

To Evaluate the Safety and PK Characteristics in Healthy Volunteers

NCT06355349 ·Status: COMPLETED ·Phase: PHASE1

Phamacokinetics and Safety Profiles of DA-1229_01 5/1000mg in Healthy Subjects at Fed State

NCT05739916 ·Status: UNKNOWN ·Phase: PHASE1

Clinical Trial to Evaluate the Pharmacokinetic Characteristics of DW5221 and DW5221-R

NCT06147908 ·Status: COMPLETED ·Phase: PHASE1

Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects

NCT05149274 ·Status: COMPLETED ·Phase: PHASE1

Phamacokinetics and Safety Profiles of DA-5210 10/1000mg in Healthy Subjects at Fed State

NCT05098886 ·Status: COMPLETED ·Phase: PHASE1

Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fed State

NCT05739877 ·Status: UNKNOWN ·Phase: PHASE1

Pharmacokinetics and Safety Profiles After Administration of DA-5211 and Co-administration of DA-5211-R1 and DA-5211-R2 in Healthy Adult Volunteers

NCT05132049 ·Status: COMPLETED ·Phase: PHASE1

To Evaluate the Pharmacokinetic Drug Interactions, Safety and Drug Tolerance in Healthy Volunteers

NCT05463497 ·Status: COMPLETED ·Phase: PHASE1

Phase 1 Study of DHP2302R1 and DHP2302R2 in Healthy Adult Volunteers

NCT06318845 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics and Safety Profiles After Administration of DA-5221_01 and Co-administration of 5221_01-R1 and DA-5221_01-R2 in Healthy Adult Volunteers

NCT06616883 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

To Evaluate the Pharmacokinetic Characteristics and Safety in Healthy Volunteers

NCT06361277 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (II)

NCT04167267 ·Status: UNKNOWN ·Phase: PHASE1